H1N1 Influenza in Pregnancy: Risks, Vaccines, and Antivirals

Pina Bozzo; Nada Djokanovic; Gideon Koren

doi:10.1016/S1701-2163(16)34378-X

H1N1 Influenza in Pregnancy: Risks, Vaccines, and Antivirals

Pina Bozzo, Nada Djokanovic, Gideon Koren

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Abstract

When pregnant women are infected by the H1N1 influenza A virus, the consequences are more serious than they are in other groups of patients. It is imperative to vaccinate pregnant women against this virus. Unvaccinated women who come in contact with the virus should receive prophylactic antiviral therapy. The existing information on the safety of oseltamavir and zanamavir, the most used antivirals, is limited but reassuring.

Original language	English
Pages (from-to)	1172-1175
Number of pages	4
Journal	Journal of Obstetrics and Gynaecology Canada
Volume	31
Issue number	12
DOIs	https://doi.org/10.1016/S1701-2163(16)34378-X
State	Published - 2009
Externally published	Yes

Keywords

Antiviral medication
H1N1 influenza A
Influenza
Pregnancy
Vaccination

Access to Document

10.1016/S1701-2163(16)34378-X

Cite this

@article{dd99bfec29ed4e2b9d290c19d5a016e2,

title = "H1N1 Influenza in Pregnancy: Risks, Vaccines, and Antivirals",

abstract = "When pregnant women are infected by the H1N1 influenza A virus, the consequences are more serious than they are in other groups of patients. It is imperative to vaccinate pregnant women against this virus. Unvaccinated women who come in contact with the virus should receive prophylactic antiviral therapy. The existing information on the safety of oseltamavir and zanamavir, the most used antivirals, is limited but reassuring.",

keywords = "Antiviral medication, H1N1 influenza A, Influenza, Pregnancy, Vaccination",

author = "Pina Bozzo and Nada Djokanovic and Gideon Koren",

note = "Publisher Copyright: {\textcopyright} 2009 Society of Obstetricians and Gynaecologists of Canada.",

year = "2009",

doi = "10.1016/S1701-2163(16)34378-X",

language = "אנגלית",

volume = "31",

pages = "1172--1175",

journal = "Journal of Obstetrics and Gynaecology Canada",

issn = "1701-2163",

publisher = "Elsevier Inc.",

number = "12",

}

TY - JOUR

T1 - H1N1 Influenza in Pregnancy

T2 - Risks, Vaccines, and Antivirals

AU - Bozzo, Pina

AU - Djokanovic, Nada

AU - Koren, Gideon

PY - 2009

Y1 - 2009

N2 - When pregnant women are infected by the H1N1 influenza A virus, the consequences are more serious than they are in other groups of patients. It is imperative to vaccinate pregnant women against this virus. Unvaccinated women who come in contact with the virus should receive prophylactic antiviral therapy. The existing information on the safety of oseltamavir and zanamavir, the most used antivirals, is limited but reassuring.

AB - When pregnant women are infected by the H1N1 influenza A virus, the consequences are more serious than they are in other groups of patients. It is imperative to vaccinate pregnant women against this virus. Unvaccinated women who come in contact with the virus should receive prophylactic antiviral therapy. The existing information on the safety of oseltamavir and zanamavir, the most used antivirals, is limited but reassuring.

KW - Antiviral medication

KW - H1N1 influenza A

KW - Influenza

KW - Pregnancy

KW - Vaccination

UR - http://www.scopus.com/inward/record.url?scp=77449103609&partnerID=8YFLogxK

U2 - 10.1016/S1701-2163(16)34378-X

DO - 10.1016/S1701-2163(16)34378-X

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 20085683

AN - SCOPUS:77449103609

SN - 1701-2163

VL - 31

SP - 1172

EP - 1175

JO - Journal of Obstetrics and Gynaecology Canada

JF - Journal of Obstetrics and Gynaecology Canada

IS - 12

ER -

H1N1 Influenza in Pregnancy: Risks, Vaccines, and Antivirals

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this